查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854800

近距离放射治疗设备市场（依产品类型、应用、放射源类型及最终用户划分）－2025-2032年全球预测

Brachytherapy Devices Market by Product Type, Application, Source Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，近距离放射治疗设备市场规模将达到 40.3 亿美元，复合年增长率为 13.99%。

关键市场统计数据
基准年 2024 14.1亿美元
预计年份：2025年 16亿美元
预测年份 2032 40.3亿美元
复合年增长率 (%) 13.99%

本文概述了近距离放射治疗设备在当代肿瘤治疗中不断演变的作用、临床需求、创新驱动因素以及相关人员的决策重点。

近距离放射治疗设备仍然是精准放射治疗的基石，它将局部剂量传递与优先考虑器官保护和功能预后的临床通讯协定相结合。目前的技术格局涵盖了成熟的密封源治疗和不断演进的输送系统，这些系统旨在降低手术复杂性并提高剂量适形性。临床医生、医院管理者和技术投资者正在评估这些治疗方法，并将其与竞争性的外照射疗法、患者吞吐量压力以及支持多学科肿瘤团队的整合式诊疗路径的需求进行比较。

本导言概述了构成当前策略环境的关键临床驱动因素和创新方向。它重点阐述了设备人体工学、施用器设计、源处理物流以及相关数位化解决方案如何影响医院的采购週期和临床应用决策。后续分析围绕着临床有效性、安全通讯协定和营运整合展开，将技术趋势与相关人员为保持竞争力和临床相关性而必须考虑的实际问题连结起来。

找出将透过技术融合、临床工作流程整合和政策主导的必要措施重塑近距离放射治疗设备格局的变革性转变。

近距离放射治疗领域正受到多种因素的共同影响而再形成，这些因素共同改变了临床工作流程和商业模式。技术融合尤为显着。影像导引定位、模组化施源器以及改进的治疗计画软体，使得放射源定位更加精准，治疗计画更具适应性，从而降低了不同肿瘤部位的治疗差异，并扩大了合格。同时，工作流程自动化和混合手术室的出现，减轻了手术室和介入团队的手术负担，使当日或门诊治疗模式成为可能。

不断变化的法规和对辐射安全日益增长的关注促使製造商投资于密封源管理和用户友好的屏蔽解决方案，而支付方则越来越重视基于价值的治疗结果，将手术选择与患者报告的指标和长期毒性特征联繫起来。同时，供应链的韧性和零件采购的在地化也变得日益重要，推动了双重采购和区域製造伙伴关係等策略的发展。设备设计的进步影响着治疗路径的整合，监管重点推动设计检验，而报销框架则影响哪些创新能够规模化应用。

评估美国于 2025 年实施关税对近距离放射治疗设备供应链、临床进入途径和采购弹性策略的累积影响

2025年即将生效的医疗设备组件和放射源关税的实施，为製造商、医疗服务提供者和经销商带来了新的营运和策略挑战。采购团队正在重新评估供应商关係、前置作业时间缓衝和库存策略，以应对潜在的成本波动，同时确保医疗服务的连续性。因应措施包括重新谈判长期供应合约、调整物流路线，以及与区域供应商更紧密合作，以减轻跨境成本调整的影响。

在临床方面，医院和专科癌症中心正在实施库存管理和优先排序通讯协定，以确保高风险病例能够及时获得所需资源。製造商正在加快对替代组件供应商进行资格认证，并检验不同製造地的等效性，以便在不影响品质保证流程的前提下调整生产。同时，商业团队正在调整合约方式和服务组合，以维持客户的整体医疗提案，并强调提供整合的培训、维护和供应商管理支持，从而在主导不确定性中保持临床合作伙伴的信心。

结合产品类型、临床应用、放射源类型和最终用户环境等关键细分因素，为制定有针对性的临床和商业策略提供资讯。

以市场区隔主导的观点揭示了不同的动态，从而为产品开发和上市决策提供基础。以产品类型（高剂量率、低剂量率、脉衝剂量率）评估，高剂量率系统因其操作高效且适用于多种临床适应症而持续吸引投资。脉衝剂量率则占据独特的市场定位，适用于放射生物学原理和患者个体化因素更倾向于间歇性剂量传递的场合。

在乳癌、子宫颈癌、眼部肿瘤和摄护腺癌等临床应用进行细分后发现，临床证据、指引核准和多专业团队的采纳是推动市场需求的主要因素。例如，前列腺癌的治疗流程通常需要整合影像技术和高精度施源器，而眼科治疗则优先考虑微源处理和专用准直器。放射源类型（Cs-137、I-125、Ir-192 和 Pd-103）的差异会影响处理、半衰期物流、监管核准和剂量计画。对最终用户（包括门诊手术中心、癌症研究中心和医院）的细分錶明，不同的采购模式和营运限制各不相同。门诊手术中心寻求紧凑、高效且支援高通量的系统；研究中心优先考虑模组化设计和用于临床实验方案的检测功能；而医院则需要完善的服务协议以及与现有放射治疗设备的整合。这种细分有助于制定产品蓝图、临床培训投资和商业性提案主张，从而确保产品与特定使用者需求和流程基础设施保持一致。

美洲、欧洲、中东和非洲以及亚太地区的区域优先事项和差异化成长驱动因素将影响临床应用和采购动态。

区域动态持续决定着各地区的采纳速度和部署策略。在美洲，先进的临床基础设施和完善的报销机制促进了迭代式医疗器材创新技术的早期应用，而成本控制压力和采购週期则要求企业提供令人信服的整体医疗成本分析。欧洲、中东和非洲的情况则较为复杂，协调一致的监管环境、区域采购联盟以及多样化的临床能力塑造了差异化的参与策略策略。亚太地区的特点是三级癌症治疗中心的容量快速扩张、微创手术的积极推广以及本地製造能力的不断提升，这些因素共同构成了国际开发商面临的竞争挑战和合作开发机会。

每个地区在培训、监管申报和上市后监测方面都需要采取细緻入微的方法。相关人员必须考虑到临床指南、操作人员技能水平和设施布局的差异，製造商应优先考虑可自订的模组化解决方案，以满足当地的流程和基础设施要求。与区域临床领导者建立策略伙伴关係，并投资于可扩展的培训项目，对于将最初的兴趣转化为这些不同市场中一致的临床应用至关重要。

深入了解与领先製造商和创新者的合作关係、智慧财产权定位以及塑造该行业动态的服务导向提案，从而获得竞争和企业层面的洞察。

近距离放射治疗领域的竞争格局呈现出传统製造商、新兴设备创新者和专业服务供应商三者融合的趋势。现有企业凭藉完善的服务网络、良好的监管记录以及包含施源器、放射源和计划软体的整合产品组合来脱颖而出。新参与企业则试图透过在使用者人体工学、放射源输送机制以及云端治疗计画等方面进行创新来取代现有企业，从而降低现场运算需求。

策略性企业行动包括与影像和肿瘤软体供应商建立合作关係，以提供端到端的治疗路径；投资于施用器形状和源封装相关的智慧财产权；以及拓展附加价值服务，例如远端培训、维护即服务和库存管理。观察到的商业性策略专注于与领先的临床中心开展概念概念验证项目，以加速产生同行评审的证据；此外，还采用分级定价模式，以反映终端用户的异质性，涵盖从高流量门诊手术中心到复杂的三级医院。这些策略共同塑造了公司的竞争定位，并影响与医疗系统采购委员会的采购谈判。

为行业领导者提供可操作的建议，以使其研发、商业模式、供应链韧性和相关人员参与与不断变化的临床和政策要求保持一致。

产业领导者应优先考虑倡议。这些倡议包括影像整合、应用器模组化以及简化的来源处理流程，从而缩短手术时间并减少手术差异。其次，企业应制定稳健的供应链多元化计划，包括可行的替代供应商和区域生产方案，以降低关税和物流波动的影响，并为医疗服务提供者合作伙伴提供透明的库存管治工具。

第三，商业策略应强调捆绑销售，并提供培训、维护和供应商管理等服务，以确保客户生命週期经济效益的可预测性。第四，与领先的临床中心建立正式伙伴关係，推动积极证据的产生和指南的采纳，有助于建立持续的临床偏好。最后，积极与监管机构和支付方沟通，阐明安全性、有效性和价值提案，可以促进产品推广，并使报销结构与患者和医疗系统的长期利益保持一致。实施这些建议需要跨部门的共同努力，以及与临床应用和服务绩效相关的可衡量的关键绩效指标 (KPI)。

透明的调查方法，详细说明资料来源、定性和定量分析方法、相关人员访谈以及检验步骤，以确保研究的严谨性和可重复性。

本摘要的分析基于以下几个方面：与关键相关人员的沟通、技术文献的综合分析，以及对公开的监管和临床指南文件的三角比较。主要资讯来源包括与放射肿瘤科医师、医学物理学家、采购负责人和临床工程师的结构化访谈，旨在检验实际工作流程、设备操作痛点和采购理由。次要资讯来源则着重于同侪审查的临床结果文献、设备安全通告和操作指南，以将设备特性与临床适应症相匹配。

分析技术包括交叉细分综合分析，用于识别产品属性与临床应用案例之间的契合度；情境分析，用于探索供应链衝击和关税的影响；以及对竞争性提案主张进行定性基准分析。检验步骤包括与临床医生和生物医学工程师进行专家评审，以确认建议的技术准确性和适用性。在条件允许的情况下，所有论点均由多个独立资讯来源提供支持，以确保其稳健性和对临床、采购和企业策略等各领域决策者的相关性。

简明扼要的结论，整合了策略意义、营运风险以及对临床、商业和监管相关人员的优先机会。

总之，近距离放射治疗设备在肿瘤治疗领域占有策略性地位，兼具精准性、器官保留和手术效率。输送系统的技术进步、不断变化的监管预期以及支付方对基于价值的治疗结果的重视，共同为设备开发商和临床应用者带来了机会和挑战。供应链压力和关税导致的成本动态变化需要积极的应对策略，而区域性的培训和服务提供方式将决定不同医疗保健系统应用的速度和品质。

成功整合临床证据产生、模组化产品设计和稳健商业模式的相关人员，更有可能赢得长期的临床伙伴关係。透过强调与现有肿瘤工作流程的互通性、强化以用户为中心的设计，以及投资于与领先临床中心开展的合作证据项目，各机构可以将创新转化为可衡量的临床和运营价值。未来的发展方向是优先考虑既能解决日常操作难题，又能推进长期治疗目标的实用性创新。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将磁振造影和超音波即时影像整合用于近距离放射治疗治疗计划和实施
  • 使用 3D 列印的患者专用近距离放射治疗施用器可以提高剂量一致性并减少设定时间。
  • 开发新型低剂量率同位素，例如铯-131，以加速放射性崩坏并改善患者预后。
  • 人工智慧驱动的治疗计画软体应运而生，能够实现精准的种子植入并降低手术风险。
  • 新兴市场对磁振造影引导近距离近距离放射治疗的日益普及，得益于有利的报销政策。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按产品类型分類的近距离放射治疗设备市场

  • 高剂量率
  • 低剂量率
  • 脉衝剂量率

第九章 按应用分類的近距离放射治疗设备市场

  • 乳癌
  • 子宫颈癌
  • 眼部肿瘤
  • 摄护腺癌

第十章 依来源类型分類的近距离放射治疗设备市场

  • 铯-137
  • I-125
  • 铱-192
  • Pd-103

第十一章 按最终用户分類的近距离放射治疗设备市场

  • 门诊手术中心
  • 癌症研究中心
  • 医院

第十二章 各地区近距离放射治疗设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 近距离放射治疗设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国近距离放射治疗设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Varian Medical Systems, Inc.
    • Elekta AB（publ）
    • Ion Beam Applications SA
    • CR Bard, Inc.
    • Eckert & Ziegler AG
    • Theragenics Corporation
    • IsoRay, Inc.
    • Proxima Therapeutics, Inc.
    • Shanghai Atom High-Tech Co., Ltd.
    • Best Medical International, Inc.
Product Code: MRR-957C47F94A6F

The Brachytherapy Devices Market is projected to grow by USD 4.03 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.41 billion
Estimated Year [2025] USD 1.60 billion
Forecast Year [2032] USD 4.03 billion
CAGR (%) 13.99%

Framing the evolving role of brachytherapy devices in contemporary oncology care, outlining clinical imperatives, innovation drivers, and stakeholder decision priorities

Brachytherapy devices remain a cornerstone of precision radiotherapy, combining localized dose delivery with clinical protocols that prioritize organ preservation and functional outcomes. The technology landscape now spans established sealed-source treatments and evolving delivery systems that seek to reduce procedural complexity while improving dosimetric conformity. Clinicians, hospital administrators, and technology investors are evaluating these modalities against competing external-beam approaches, patient throughput pressures, and the need for integrated care pathways that support multidisciplinary oncology teams.

This introduction outlines the principal clinical drivers and innovation vectors that define the current strategic environment. Emphasis is given to how device ergonomics, applicator design, source handling logistics, and adjacent digital solutions are informing hospital procurement cycles and clinical adoption decisions. By framing the discussion around clinical efficacy, safety protocols, and operational integration, the subsequent analysis will connect technological trends with pragmatic considerations that stakeholders must address to maintain competitive and clinical relevance.

Identifying transformative shifts reshaping the brachytherapy device landscape through technology convergence, clinical workflow integration, and policy-driven imperatives

The brachytherapy landscape is being reshaped by several converging forces that collectively alter clinical workflows and commercial models. Technological convergence is prominent: improvements in imaging-guided placement, applicator modularity, and treatment planning software are enabling more precise source positioning and adaptive planning, thereby reducing variability and broadening eligibility across tumor sites. At the same time, workflow automation and hybrid procedural suites are lowering the procedural burden on operating rooms and interventional teams, which makes same-day or ambulatory delivery models more feasible.

Regulatory evolution and heightened attention to radiation safety have prompted manufacturers to invest in sealed-source management and user-friendly shielding solutions, while payers increasingly emphasize value-based outcomes that link procedural choice to patient-reported metrics and long-term toxicity profiles. Simultaneously, supply-chain resilience and localization of component sourcing have grown in importance, catalyzing strategies such as dual-sourcing and regional manufacturing partnerships. These transformative shifts are interdependent: advances in device design influence care-pathway integration, regulatory priorities drive design validation, and reimbursement frameworks affect which innovations achieve scale.

Assessing the cumulative impact of United States tariffs in 2025 on brachytherapy device supply chains, clinical access pathways, and procurement resilience strategies

The introduction of tariffs in 2025 affecting medical device components and radioactive sources has created a new layer of operational and strategic complexity for manufacturers, providers, and distributors. Procurement teams are reassessing supplier relationships, lead-time buffers, and inventory strategies to absorb potential cost fluctuations while preserving treatment continuity. Reaction pathways include renegotiation of long-term supply agreements, reconfiguration of logistic routing, and closer collaboration with regional suppliers to mitigate exposure to cross-border cost adjustments.

Clinically, hospitals and specialized cancer centers are implementing inventory governance and prioritization protocols to ensure uninterrupted access for high-acuity cases. Manufacturers are accelerating efforts to qualify alternative component sources and to validate equivalence across manufacturing sites so that production can pivot without compromising quality assurance processes. In parallel, commercial teams are recalibrating contracting approaches and service bundles to preserve total-cost-of-care propositions for customers, emphasizing integrated training, maintenance, and source management support to maintain clinical partners' confidence amid tariff-driven uncertainty.

Key segmentation insights synthesizing product types, clinical applications, radioactive source varieties, and end-user settings to inform targeted clinical and commercial strategies

A segmentation-led perspective reveals differentiated dynamics that inform product development and go-to-market decisions. When evaluating by product type-High Dose Rate, Low Dose Rate, and Pulsed Dose Rate-High Dose Rate systems continue to attract investment for their procedural efficiency and versatility across multiple clinical indications, while Low Dose Rate offerings maintain relevance for certain ocular and prostate protocols where prolonged source residency aligns with established practice. Pulsed Dose Rate occupies a niche role where radiobiological rationale and patient-specific considerations favor intermittent dose delivery.

Clinical application segmentation across Breast Cancer, Cervical Cancer, Ocular Tumors, and Prostate Cancer highlights where clinical evidence, guideline endorsement, and multidisciplinary team adoption converge to drive demand. For instance, prostate workflows often require integrated imaging and precision applicators, whereas ocular treatments prioritize microsource handling and specialized collimation. Source type distinctions-Cs-137, I-125, Ir-192, and Pd-103-carry implications for handling, half-life logistics, regulatory licensing, and dosimetric planning; institutions weigh these attributes when aligning procurement with clinical caseload profiles. End-user segmentation, covering Ambulatory Surgical Centres, Cancer Research Centers, and Hospitals, signals divergent purchasing models and operational constraints: ambulatory centers seek compact, efficient systems that support high throughput, research centers prioritize modularity and assay capability for investigational protocols, and hospitals require robust service agreements and integration with existing radiotherapy suites. These segmentation lenses should drive product roadmaps, clinical training investments, and commercial articulation of value propositions to ensure alignment with specific user needs and procedural infrastructures.

Regional priorities and differentiated growth enablers across Americas, Europe, Middle East & Africa, and Asia-Pacific that influence clinical adoption and procurement dynamics

Regional dynamics continue to dictate adoption velocity and deployment strategies across distinct geographies. In the Americas, advanced clinical infrastructure and established reimbursement pathways facilitate early adoption of iterative device innovations, although cost containment pressures and procurement cycles require compelling total-cost-of-care narratives. Europe, Middle East & Africa present a heterogeneous landscape in which regulatory harmonization, regional procurement consortia, and variable clinical capacity shape differentiated entry strategies; partnerships with regional distributors and locally tailored service models often determine longer-term presence. Asia-Pacific is characterized by rapid capacity expansion in tertiary oncology centers, aggressive adoption of minimally invasive procedures, and increasing local manufacturing capabilities, which together create both competitive challenges and collaboration opportunities for foreign developers.

Each region demands nuanced approaches to training, regulatory submissions, and post-market surveillance. Stakeholder engagement must account for variations in clinical guidelines, operator skill levels, and facility layouts, and manufacturers should prioritize modular solutions that can be customized to local procedural and infrastructure requirements. Strategic alliances with regional clinical leaders and investment in scalable training programs are essential to transform early interest into consistent clinical utilization across these diverse markets.

Competitive and corporate insights into leading manufacturers, innovator partnerships, intellectual property positioning, and service-oriented propositions shaping sector dynamics

Competitive dynamics in the brachytherapy sector reflect a blend of legacy manufacturers, emerging device innovators, and specialized service providers. Established firms differentiate on comprehensive service networks, regulatory track records, and integrated product suites that bundle applicators, sources, and planning software. New entrants seek to displace incumbents through focused innovation in user ergonomics, source delivery mechanisms, and cloud-enabled treatment planning that reduces on-site computational requirements.

Strategic corporate behaviors include alliance formation with imaging and oncology software vendors to deliver end-to-end treatment pathways, investment in intellectual property around applicator geometries and source encapsulation, and expansion of value-added services such as remote training, maintenance-as-a-service, and inventory management. Observed commercial tactics emphasize proof-of-concept programs with leading clinical centers to accelerate peer-reviewed evidence generation, and tiered pricing models that reflect the heterogeneity of end users from high-volume ambulatory surgery centers to complex tertiary hospitals. These approaches collectively shape competitive positioning and influence purchasing discussions with health system procurement committees.

Actionable recommendations for industry leaders to align research and development, commercial models, supply resilience, and stakeholder engagement with evolving clinical and policy demands

Industry leaders should prioritize initiatives that enhance clinical value while strengthening operational resilience. First, aligning R&D investments to demonstrable clinical outcomes and user ergonomics will accelerate clinician adoption; this includes prioritizing imaging integration, applicator modularity, and simplified source handling processes that reduce procedure time and variability. Second, companies should build robust supply-chain diversification plans that include validated alternative suppliers and regional production options to mitigate tariff and logistics volatility, coupled with transparent inventory governance tools for provider partners.

Third, commercial strategies should emphasize bundled service offerings-training, maintenance, and source management-to preserve predictable lifecycle economics for customers. Fourth, establishing formal partnerships with leading clinical centers to drive prospective evidence generation and guideline inclusion will create durable clinical preference. Finally, engaging proactively with regulators and payers to articulate safety, efficacy, and value propositions can smooth adoption pathways and align reimbursement structures with long-term patient and system benefits. Implementing these recommendations will require cross-functional commitment and measurable KPIs linked to clinical adoption and service performance.

Transparent research methodology detailing data sources, qualitative and quantitative analytical approaches, stakeholder interviews, and validation steps ensuring rigor and reproducibility

The analysis underpinning this summary was developed through a combination of primary stakeholder engagement, technical literature synthesis, and triangulation of publicly available regulatory and clinical guidance documents. Primary inputs included structured interviews with practicing radiation oncologists, medical physicists, procurement officers, and clinical engineers to validate real-world workflows, device handling pain points, and procurement rationales. Secondary inputs focused on peer-reviewed clinical outcomes literature, device safety notices, and procedural guidelines to map clinical indications to device capabilities.

Analytical methods included cross-segmentation synthesis to identify where product attributes align with clinical use-cases, scenario analysis to explore supply-chain shocks and tariff impacts, and qualitative benchmarking across competing value propositions. Validation steps comprised expert review sessions with practicing clinicians and biomedical engineers to confirm technical accuracy and applicability of recommendations. Wherever possible, assertions were corroborated by multiple independent sources to ensure robustness and relevance to decision-makers across clinical, procurement, and corporate strategy functions.

Concise conclusion synthesizing strategic implications, operational risks, and priority opportunities for clinical, commercial, and regulatory stakeholders

In conclusion, brachytherapy devices occupy a strategic niche in oncology care where precision, organ preservation, and procedural efficiency intersect. The combination of technological refinements in delivery systems, evolving regulatory expectations, and payer emphasis on value-based outcomes creates both opportunity and complexity for device developers and clinical adopters. Supply-chain pressures and tariff-induced cost dynamics require proactive mitigation strategies, while regionally tailored approaches to training and service delivery will determine the pace and quality of adoption across diverse healthcare systems.

Stakeholders that successfully integrate clinical evidence generation, modular product design, and resilient commercial models will be best positioned to capture long-term clinical partnerships. By focusing on interoperability with existing oncology workflows, enhancing user-centric design, and investing in collaborative evidence programs with leading clinical centers, organizations can translate innovation into measurable clinical and operational value. The path forward emphasizes pragmatic innovation that addresses daily procedural realities as much as it advances long-term therapeutic goals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of MRI and ultrasound real-time imaging for adaptive brachytherapy treatment planning and delivery
  • 5.2. Adoption of 3D-printed patient-specific brachytherapy applicators to improve dose conformity and reduce setup time
  • 5.3. Development of novel low-dose-rate isotopes like cesium-131 for faster radiation decay and improved patient outcomes
  • 5.4. Introduction of compact high-dose-rate afterloaders enabling outpatient brachytherapy and reduced hospital stays
  • 5.5. Emergence of AI-driven treatment planning software for precise seed placement and reduced procedural risks
  • 5.6. Expansion of MR-guided brachytherapy adoption in emerging markets driven by favorable reimbursement policies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brachytherapy Devices Market, by Product Type

  • 8.1. High Dose Rate
  • 8.2. Low Dose Rate
  • 8.3. Pulsed Dose Rate

9. Brachytherapy Devices Market, by Application

  • 9.1. Breast Cancer
  • 9.2. Cervical Cancer
  • 9.3. Ocular Tumors
  • 9.4. Prostate Cancer

10. Brachytherapy Devices Market, by Source Type

  • 10.1. Cs-137
  • 10.2. I-125
  • 10.3. Ir-192
  • 10.4. Pd-103

11. Brachytherapy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centres
  • 11.2. Cancer Research Centers
  • 11.3. Hospitals

12. Brachytherapy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brachytherapy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brachytherapy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Varian Medical Systems, Inc.
    • 15.3.2. Elekta AB (publ)
    • 15.3.3. Ion Beam Applications S.A.
    • 15.3.4. C. R. Bard, Inc.
    • 15.3.5. Eckert & Ziegler AG
    • 15.3.6. Theragenics Corporation
    • 15.3.7. IsoRay, Inc.
    • 15.3.8. Proxima Therapeutics, Inc.
    • 15.3.9. Shanghai Atom High-Tech Co., Ltd.
    • 15.3.10. Best Medical International, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRACHYTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BRACHYTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. CANADA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MEXICO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. BRAZIL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED KINGDOM BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. ITALY BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 338. INDIA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 339. JAPAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. JAPAN BRACHYTHERAPY DEVICES MARK